Sign In
Buy HAE
$65.88
-0.490 (-0.738%)
At Close: Jun 03, 2026
Haemonetics: Buy When There's Blood In The Streets
03:07pm, Friday, 21'st May 2021
The leading player in the market for blood plasma collection equipment. The plasma market is a duopoly with Fresenius in a distant number two position.
Haemonetics Corp: Contrarian Flavour With Recent Market Punishment
12:55pm, Tuesday, 18'th May 2021
Haemonetics shares have been punished since April on the back of CSL Plasma's decision not to renew the use of PCS2 from June 2022. Shares immediately saw a gap-fill to the downside and have shown dow
Haemonetics (HAE) Q4 Earnings Lag Estimates, Gross Margin Dips
08:16am, Monday, 17'th May 2021
Haemonetics' (HAE) fourth-quarter fiscal 2021 revenues declined 5.6% year over year due to the pandemic.
Why Haemonetics Stock Rallied on Friday
05:56pm, Friday, 14'th May 2021
One analyst upgrade in particular seemed to bring back the bulls.
Why Haemonetics Stock Fell 13% Today
06:01pm, Thursday, 13'th May 2021
Investors don't seem to be buying the company's rosy 2022 guidance.
Haemonetics Corporation (HAE) CEO Chris Simon on Q4 2021 Results - Earnings Call Transcript
01:05pm, Thursday, 13'th May 2021
Haemonetics Corporation (HAE) CEO Chris Simon on Q4 2021 Results - Earnings Call Transcript
Haemonetics (HAE) Q4 Earnings and Revenues Miss Estimates
12:55pm, Thursday, 13'th May 2021
Haemonetics (HAE) delivered earnings and revenue surprises of -31.34% and -0.06%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Haemonetics Q4 Earnings
07:11am, Thursday, 13'th May 2021
Shares of Haemonetics (NYSE:HAE) rose 2.1% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 33.33% over the past year to $0.46, which missed
Haemonetics 4th Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website
06:00am, Thursday, 13'th May 2021
BOSTON, May 13, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter fiscal 2021, which ended April 3, 2021, are available on its Investor
Haemonetics (HAE) to Report Q4 Earnings: What's in the Cards?
07:31am, Wednesday, 12'th May 2021
Continued benefits from the NexSys device and NexLynk DMS along with robust TEG devices sales are expected to have contributed to Haemonetics (HAE) fourth-quarter top line.
Analysts Estimate Haemonetics (HAE) to Report a Decline in Earnings: What to Look Out for
03:46pm, Thursday, 06'th May 2021
Haemonetics (HAE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2021 Results: May 13, 2021
04:05pm, Friday, 23'rd Apr 2021
BOSTON, April 23, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish fourth quarter and fiscal year 2021 financial results at 6:00 am EDT on Thursda
What's Next For Haemonetics Stock?
06:00am, Wednesday, 21'st Apr 2021
The stock price of Haemonetics, best known for its blood and plasma supplies and services, plunged over 36% in a single trading session yesterday. This can be attributed to one of its large customers
Haemonetics Provides Update On U.S. Plasma Business
06:00am, Monday, 19'th Apr 2021
BOSTON, April 19, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) ("Haemonetics" or the "Company"), a global medical technology company focused on delivering innovative medical solutions to
Will Haemonetics Stock Rebound After The Recent Drop?
10:00am, Monday, 05'th Apr 2021
Haemonetics stock, best known for its blood and plasma supplies and services, has fallen by 3.5% in the last week, while it is down 7% over the last ten days. HAE stock has been on a decline since it
